Food and Drug Administration： Ten kinds of drugs such as Tongluo Zhitong Capsule are illegal in advertising.
BEIJING, Feb. 21 (Xinhua) According to the website of National Medical Products Administration, the State Drug Administration announced the summary list of the third illegal drug advertisements in 2007. It is reported that the food and drug supervision and management departments at all levels have notified and transferred the illegal drug advertisements to the industrial and commercial administrative departments at the same level for investigation by issuing the Announcement of Illegal Drug Advertisements, totaling 16,378 times; Shaanxi, Liaoning and other provinces have revoked 75 drug advertisement approval numbers for illegal publicity due to serious tampering with the approval contents.
1. The "Xinshu Capsule" produced by Jilin Bencaotang Pharmaceutical Co., Ltd. has the main functions of "promoting qi and blood circulation, dredging orifices and relieving depression". It is used for chest tightness, shortness of breath and angina pectoris caused by coronary heart disease. This drug is a prescription drug. The company advertised in the mass media without authorization, and claimed that "taking Xinshu Capsule, bid farewell to heart disease … taking Xinshu Capsule for 2-3 courses, the heart function returned to normal, and cardiovascular diseases such as coronary heart disease, angina pectoris and myocardial infarction were cured". There are a lot of unscientific assertions and guarantees in advertisements, which seriously deceive and mislead consumers.
Second, the "Compound Artemisia annua Spray" produced by Kunming Pharmaceutical (Group) Co., Ltd. has the main functions of "clearing away heat and toxic materials, removing blood stasis, stopping bleeding, reducing swelling and relieving pain. It is used for inflammatory external hemorrhoids and thrombotic external hemorrhoids caused by damp-heat in large intestine. The drug advertisement claims that "it takes 30 minutes to relieve itching and pain, 1 hour to reduce swelling, and 8-10 days for anal meat pieces and hemorrhoids to dry up". Advertisements contain unscientific assertions and guarantees of efficacy, which seriously deceive and mislead consumers.
3. The "Compound Sea Snake Capsule" produced by Zhejiang Hangkang Marine Biological Pharmaceutical Co., Ltd. has the main function of "tonifying kidney and calming the heart, resolving phlegm and calming the nerves". The drug advertisement claims to be "a good opportunity for patients with brain atrophy, Alzheimer’s disease, cerebral palsy, Parkinson’s disease and stroke epilepsy to be rescued". The propaganda of product function and indication in advertisements is beyond the content approved by the food and drug supervision and administration department, and contains unscientific assertions and guarantees indicating efficacy, which seriously deceives and misleads consumers.
4. The "Gujin Pill Capsule" produced by Shenyang Oasis Pharmaceutical Co., Ltd. has the main functions of "promoting blood circulation and removing blood stasis, relaxing muscles and tendons, expelling wind and relieving pain". This drug is a prescription drug. The company advertised in the mass media without authorization, and declared that "… only two boxes of medicine were taken for cervical spondylosis, and it was able to drive again; Expel bone thrombosis and scientifically change bones for you. There are a lot of unscientific assertions and guarantees in advertisements, which seriously deceive and mislead consumers.
Five, Jilin Huinan Tiantai Pharmaceutical Co., Ltd. produced "Qianliexiao Capsule", its main function is "clearing heat and promoting diuresis. It is used for patients with prostatitis with scorching damp-heat syndrome, and the symptoms are frequent urination, urgency, astringent pain, endless urination, soreness of waist and knees, etc. This drug is a prescription drug. The company released advertisements in the mass media without authorization, claiming that "it is the first drug in China that can clear prostate gland poison, and its unique adenolytic enzyme softens and disintegrates gland poison from the inside, restores male function, and comprehensively treats prostate diseases". The advertisements not only contain unscientific assertions and guarantees of efficacy, but also fabricate the product mechanism, which seriously deceives and misleads consumers.
6. "Mannatide Oral Liquid" produced by Pharmaceutical Factory of Shaanxi Academy of Sciences, its indication is "used for adjuvant treatment of hypoimmunity, recurrent respiratory infection, leukopenia, aplastic anemia and tumor, to reduce the side effects of radiotherapy and chemotherapy on hematopoietic system, and used for patients with chronic hepatitis B". The drug advertisement claims that "the general patients take 3-5 courses of treatment, the clinical symptoms basically disappear, and the tumor body gradually shrinks, so it is the first choice for patients with dangerous and severe advanced tumors". The publicity of product functions and indications in advertisements is beyond the content approved by the food and drug administration, and contains a large number of unscientific assertions and guarantees indicating efficacy, which seriously deceives and misleads consumers.
Seven, Qingdao Haier Pharmaceutical Co., Ltd. produced "Haimingwei brand Haiqi Shugan capsule", its main function is "resolving phlegm and resolving hard mass, promoting diuresis and expelling toxin. It can be used for costal pain, swelling, abdominal distension, anorexia, nausea and fatigue caused by phlegm stagnation. It is also used for adjuvant treatment with the above performance after tumor radiotherapy and chemotherapy. " This drug is a prescription drug. The company advertised in the mass media without authorization, and claimed that the product was "the first choice for treating hepatitis B, all patients with hepatitis B" big three positive "turned negative, and patients with hepatitis B" small three positive "fully recovered". The advertisement’s propaganda on the product’s function and indication goes beyond the content approved by the food and drug supervision and management department, and uses the patient’s image to prove the efficacy of the drug, which contains unscientific assertions and guarantees that indicate the efficacy, seriously deceiving and misleading consumers.
Eight, Jilin Yongli Pharmaceutical Co., Ltd. produced "refined Guanxin soft capsule", its main function is "promoting blood circulation and removing blood stasis. It is used for coronary heart disease and angina pectoris due to blood stasis. This drug is a prescription drug. The company advertised in the mass media without authorization, and declared that "new Chinese medicine can replace heart surgery". The propaganda of product function and indication in advertisements is beyond the content approved by the food and drug supervision and administration department, and contains unscientific assertions and guarantees indicating efficacy, which seriously deceives and misleads consumers.
Nine, Qinghai Jinhe Tibetan Medicine Pharmaceutical Co., Ltd. produces "Seventy Flavor Pearl Pills", whose main functions are "calming the nerves, calming down, dredging meridians, harmonizing qi and blood, refreshing the brain and inducing resuscitation". This drug is a prescription drug. The company advertised in the mass media without authorization, and declared that "only one pill in 7 days can cure the heart and brain easily". Advertisements contain unscientific assertions and guarantees of efficacy, which seriously deceive and mislead consumers.
X "Tongluo Zhitong Capsule" produced by Shanxi Chuanglong Pharmaceutical Co., Ltd. has the main function of "clearing away heat and promoting diuresis, dredging collaterals and relieving pain". It is used for adjuvant treatment of joint swelling and pain, heavy limbs and unfavorable activities caused by arthralgia due to dampness-heat blocking collaterals. " The drug advertisement claims that "it takes 2-3 days to stop the pain, 30 days for the joint to move autonomously, and 3 months for moderate patients to stop taking the drug". Advertisements use the name of experts to prove the efficacy of drugs, and contain unscientific assertions and guarantees indicating efficacy, which seriously deceive and mislead consumers.
National Medical Products Administration demanded. The food and drug supervision and administration departments of all provinces, autonomous regions and municipalities directly under the Central Government should continue to strengthen the monitoring of drug advertisements. The illegal drug advertisements found shall be transferred to the administrative department for industry and commerce in a timely manner, and the bad behaviors of enterprises that illegally publish advertisements shall be recorded in accordance with the provisions of the Measures for the Credit Management of Enterprises that Publish Illegal Drugs, Medical Devices and Health Food Advertisements; In accordance with the relevant provisions of the Measures for the Examination of Drug Advertisements, administrative compulsory measures such as suspension of sales should be taken for drugs involved in serious illegal advertisements, and the approval number of drug advertisements that are illegally released without authorization should be resolutely revoked; It is necessary to increase publicity to the public and improve consumers’ ability to identify illegal drug advertisements.
Editor: Yin Wei